W.G. Shaheen & Associates DBA Whitney & Co Purchases New Shares in Hims & Hers Health, Inc. $HIMS

W.G. Shaheen & Associates DBA Whitney & Co purchased a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 7,345 shares of the company’s stock, valued at approximately $366,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HIMS. Signaturefd LLC lifted its stake in shares of Hims & Hers Health by 17.7% during the first quarter. Signaturefd LLC now owns 2,586 shares of the company’s stock valued at $76,000 after acquiring an additional 388 shares during the period. Ethic Inc. acquired a new stake in shares of Hims & Hers Health during the second quarter worth $348,000. Lake Hills Wealth Management LLC acquired a new stake in shares of Hims & Hers Health during the second quarter worth $277,000. Occidental Asset Management LLC acquired a new stake in shares of Hims & Hers Health during the second quarter worth $305,000. Finally, Dakota Wealth Management acquired a new stake in shares of Hims & Hers Health during the second quarter worth $354,000. 63.52% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently commented on HIMS. Zacks Research cut Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 19th. KeyCorp began coverage on Hims & Hers Health in a research note on Tuesday, October 21st. They set a “sector weight” rating for the company. Truist Financial decreased their price objective on Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating for the company in a research note on Monday, August 18th. Wall Street Zen cut Hims & Hers Health from a “buy” rating to a “hold” rating in a research note on Monday, July 28th. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $68.00 target price on shares of Hims & Hers Health in a report on Friday, September 12th. Two research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $38.92.

Insider Activity

In other news, insider Michael Chi sold 900 shares of the business’s stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $58.25, for a total value of $52,425.00. Following the sale, the insider directly owned 291,439 shares in the company, valued at $16,976,321.75. The trade was a 0.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Soleil Boughton sold 2,637 shares of the business’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $50.10, for a total value of $132,113.70. Following the completion of the sale, the insider owned 158,493 shares in the company, valued at approximately $7,940,499.30. This trade represents a 1.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 1,432,271 shares of company stock worth $74,229,585 over the last three months. Corporate insiders own 17.71% of the company’s stock.

Hims & Hers Health Stock Up 3.4%

Shares of Hims & Hers Health stock opened at $45.55 on Monday. Hims & Hers Health, Inc. has a 1 year low of $18.33 and a 1 year high of $72.98. The business has a 50-day moving average of $51.39 and a two-hundred day moving average of $50.61. The company has a market capitalization of $10.30 billion, a P/E ratio of 56.94, a price-to-earnings-growth ratio of 3.15 and a beta of 2.20. The company has a debt-to-equity ratio of 1.72, a current ratio of 4.98 and a quick ratio of 4.46.

Hims & Hers Health (NYSE:HIMS) last announced its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The business had revenue of $544.83 million during the quarter, compared to the consensus estimate of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.The firm’s revenue was up 72.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.06 earnings per share. As a group, equities analysts predict that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.